Showing codes Q9959 (High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml) — Q9991 (Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg)

Q9959 - Hocm 150-199mg/ml iodine,1ml
Long description: High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9960 - Hocm 200-249mg/ml iodine,1ml
Long description: High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9961 - Hocm 250-299mg/ml iodine,1ml
Long description: High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9962 - Hocm 300-349mg/ml iodine,1ml
Long description: High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9963 - Hocm 350-399mg/ml iodine,1ml
Long description: High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9964 - Hocm>= 400mg/ml iodine, 1ml
Long description: High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9965 - Locm 100-199mg/ml iodine,1ml
Long description: Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9966 - Locm 200-299mg/ml iodine,1ml
Long description: Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9967 - Locm 300-399mg/ml iodine,1ml
Long description: Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9968 - Visualization adjunct
Long description: Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
Code added date: 20100101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9969 - Non-heu tc-99m add-on/dose
Long description: Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
Code added date: 20130101.
Code effective date: 20130101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9970 - Inj ferric carboxymaltos 1mg
Long description: Injection, ferric carboxymaltose, 1mg
Code added date: 20140701.
Code effective date: 20150101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9972 - Epoetin beta esrd use
Long description: Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
Code added date: 20140701.
Code effective date: 20150101.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9973 - Epoetin beta non esrd
Long description: Injection, epoetin beta, 1 microgram, (non-esrd use)
Code added date: 20140701.
Code effective date: 20150101.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9974 - Morphine epidural/intratheca
Long description: Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
Code added date: 20140701.
Code effective date: 20150101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9975 - Factor viii fc fusion recomb
Long description: Injection, factor viii fc fusion protein (recombinant), per iu
Code added date: 20150401.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9976 - Inj ferric pyrophosphate cit
Long description: Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
Code added date: 20150701.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9977 - Compounded drug noc
Long description: Compounded drug, not otherwise classified
Code added date: 20150701.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9978 - Netupitant palonosetron oral
Long description: Netupitant 300 mg and palonosetron 0.5 mg
Code added date: 20150701.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9979 - Injection, alemtuzumab
Long description: Injection, alemtuzumab, 1 mg
Code added date: 20151001.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9980 - Genvisc, inj, 1mg
Long description: Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
Code added date: 20160101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9981 - Rolapitant, oral, 1mg
Long description: Rolapitant, oral, 1 mg
Code added date: 20160701.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9982 - Flutemetamol f18 diagnostic
Long description: Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
Code added date: 20160701.
Code effective date: 20190101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9983 - Florbetaben f18 diagnostic
Long description: Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
Code added date: 20160701.
Code effective date: 20190101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9984 - Kyleena, 19.5 mg
Long description: Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
Code added date: 20170701.
Code effective date: 20180101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

Q9985 - Inj hydroxyprogst capoat nos
Long description: Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
Code added date: 20170701.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9986 - Makena, 10 mg
Long description: Injection, hydroxyprogesterone caproate, (makena), 10 mg
Code added date: 20170701.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9987 - Pathogen test for platelets
Long description: Pathogen(s) test for platelets
Code added date: 20170701.
Code effective date: 20180101.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9988 - Platelets, pathogen reduced
Long description: Platelets, pheresis, pathogen-reduced, each unit
Code added date: 20170701.
Code effective date: 20180101.
Pricing Indicator Code(s): 52 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9989 - Ustekinumab, iv inject,1 mg
Long description: Ustekinumab, for intravenous injection, 1 mg
Code added date: 20170701.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9991 - Buprenorph xr 100 mg or less
Long description: Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
Code added date: 20180701.
Code effective date: 20180701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF